Precision at Scale: Translating Neoantigen Products into Clinical Practice

• Current evidence supporting neoantigen-based therapies and their evolving role in precision oncology 
• The scientific, manufacturing, and operational challenges—and potential solutions
• Clinical infrastructure, patient pathways, regulatory considerations, and multidisciplinary collaboration needed to integrate neoantigen therapies into standard oncology care

Speakers:

Heather Shaw

Consultant Medical Oncologist

NHS